This bill requires lenders using the Uniform Residential Loan Application to add a specific disclaimer below the military service question: "If yes, you may qualify for a VA Home Loan. Consult your lender regarding eligibility." It directly affects military service members and veterans applying for home loans, aiming to increase awareness of VA loan eligibility. The bill mandates this change within six months of enactment and requires a GAO study within 18 months to assess whether at least 80% of lenders include the disclaimer on the form.
The Affordable Prescriptions for Patients Act of 2023 targets "product hopping" by pharmaceutical manufacturers, which occurs when companies discontinue an original drug to make way for a follow-on product and prevent competition from cheaper generics or biosimilars. The bill prohibits two types of anti-competitive conduct: "hard switches" (discontinuing a drug or withdrawing approval) and "soft switches" (taking actions to disadvantage the original drug relative to a follow-on product). It gives the Federal Trade Commission authority to enforce these rules, including seeking remedies like disgorgement of profits from anti-competitive behavior. This legislation directly affects drug manufacturers, particularly those producing reference drugs and follow-on products, with the goal of increasing competition in the pharmaceutical market and lowering prescription costs.
SRES 765 is a Senate resolution honoring the late Senator James M. Inhofe of Oklahoma following his death on July 9, 2024. The resolution commemorates his 28-year Senate service (1994-2023) and 52 years in public office, highlighting his work on defense policy, aviation legislation, infrastructure projects, and support for military bases in Oklahoma. This procedural resolution expresses the Senate's condolences and formally recognizes his legacy, rather than enacting any policy changes.
The "Promoting a Resolution to the Tibet-China Dispute Act" amends the Tibetan Policy Act of 2002 to clarify US policy regarding Tibet. It directs the US Special Coordinator for Tibetan Issues to counter Chinese disinformation about Tibet's history, culture, and institutions, including claims that Tibet has been part of China since ancient times. The bill specifically defines Tibetan Autonomous Regions for policy purposes and authorizes funds to support these counter-disinformation efforts. It reaffirms that Tibet has a distinct cultural identity and that dialogue between China and Tibetan representatives should occur without preconditions. The bill does not change US diplomatic relations with China but provides specific guidance for US policy implementation.
SRES 763 is a symbolic Senate resolution designating July 2024 as "Plastic Pollution Action Month." It does not create new laws or regulations but formally recognizes the environmental and health impacts of plastic pollution - citing statistics on global plastic production, low recycling rates, ocean contamination, and human microplastic exposure. The resolution encourages all U.S. individuals to voluntarily reduce plastic use, participate in cleanup efforts, and support reuse initiatives during July 2024 and year-round. It serves as a non-binding awareness tool, referencing existing public efforts like Plastics Free July and the International Coastal Cleanup. This resolution directly affects the public by promoting voluntary action, not by imposing legal requirements.
The Capping Prescription Costs Act of 2024 sets a yearly limit on out-of-pocket costs for prescription drugs under most health insurance plans. Starting in 2026, individual plan members would pay no more than $2,000 annually for covered drugs, while families would pay no more than $4,000. These limits would increase each year based on inflation, adjusted using the medical care component of the Consumer Price Index. The bill applies to both individual health plans and employer-sponsored group plans covered under the Affordable Care Act. It takes effect for plans beginning after December 2025.
This bill authorizes Congress to award a single Congressional Gold Medal to Jens Stoltenberg, former Secretary General of NATO, recognizing his leadership during his nine-year tenure. It directs the Treasury to strike the medal and allows for the sale of bronze duplicates to cover costs. The medal honors Stoltenberg's role in strengthening NATO's defense spending, enlargement, and unity - particularly during Russia's invasion of Ukraine - though the bill itself creates no new policy or obligations. The award is purely ceremonial and affects only Stoltenberg as the recipient.
This bill, S 4691 (No Tax Breaks for Drug Ads Act), removes a tax deduction for pharmaceutical companies that spend on direct-to-consumer advertising of prescription drugs. It directly affects drug manufacturers by eliminating the ability to deduct expenses for ads targeting the general public through TV, radio, print, online, or social media platforms. The key provision prohibits tax deductions for all such advertising costs starting after the bill's enactment date, without changing advertising rules or banning ads. This is a concrete tax policy change affecting pharmaceutical industry spending, not a regulatory measure.
The Federal Firearm Licensee Act would significantly strengthen regulations for federally licensed firearm dealers, manufacturers, and importers. Key provisions require dealers to implement physical security plans for their premises, conduct regular inventory checks of firearms, and maintain electronic records of all firearm transactions. The bill repeals restrictions that limited law enforcement's access to crime firearm trace data and increases penalties for violations, including civil fines and license suspensions. It also mandates background checks for dealer employees and expands reporting requirements for multiple firearm sales. This legislation directly affects all federally licensed firearm businesses operating under Chapter 44 of Title 18.
This bill prohibits distributing AI-generated election media containing serious inaccuracies about election details (like timing or voter eligibility) or falsely depicting election officials, with exemptions for news outlets that clearly disclose falsehoods in their reporting. It also restricts states from removing voters from registration rolls using unverified data, requiring all voter challenge information to come from official government sources and be approved by the Attorney General as meeting specific verification standards (e.g., including full names, SSNs, or driver's license numbers). The bill directly affects individuals distributing election media, news organizations, and state election officials managing voter rolls. Enforcement is handled by the Attorney General through civil actions for violations.
The Keep Families Together Act (S 4723) limits the separation of children from parents or legal guardians at or near the U.S. border or within 100 miles of it. It prohibits separation solely to deter migration or enforce immigration laws, allowing separation only under specific conditions: a state court order, a child welfare agency’s safety determination, or documented findings by border officials regarding trafficking, parentage, or immediate danger to the child. The bill requires agencies to document separations, provide monthly updates to families on children’s well-being, develop a public system for locating separated children, and mandate training for border agents on child welfare and trauma. It directly affects children under 18 without permanent U.S. immigration status and their families, applying to border enforcement agencies like Customs and Border Protection.
This bill (S 4554) is a non-binding resolution expressing Congress's "sense" that protections for abortion access should be supported after the *Dobbs* decision and that *Roe v. Wade* protections should be restored. It does not create new laws or change existing policies; it is solely a statement of congressional opinion. The resolution directly affects no individuals or entities, as it lacks legal force. Key provisions (Section 2) state Congress supports post-*Dobbs* reproductive health care access and aims to restore *Roe*-era protections, but these are declarative statements only.
